[ad_1]
The U.S. government plans to unveil a preliminary list of generic drugs for Medicare recipients priced at a maximum of $2, as reported by Axios. These drugs will not be subject to prior authorization or quantity limits. The initial list of 101 generic drugs will include commonly prescribed medications such as penicillin, metformin, lithium, and albuterol asthma inhalers. It will also cover medications for high cholesterol, high blood pressure, and other chronic conditions. The program is set to launch in January 2027. The Centers for Medicare & Medicaid Services have not yet commented on the report.
[ad_2]
SOURCE
Emma Collins, graduated in Financial Economics from the University of Chicago in the USA in 2016. She has since worked at an asset management firm in New York, where she specializes in investment strategies and portfolio management. Emma has a keen interest in financial analysis and has published several articles in renowned financial journals. Her work focuses on providing actionable insights to investors, and she is known for her forward-thinking approach to managing financial portfolios.
